Brendan Teehan joined Acadia in July 2018 and has more than 25 years of global experience in the healthcare industry.
Mr. Teehan has held roles of increasing responsibility at biopharmaceutical companies, including Johnson & Johnson and Amgen, and over the course of his career has led field sales, operations and marketing teams in the U.S. and Europe and successfully launched small and large molecule products. Mr. Teehan began his career with Johnson & Johnson, where he held a variety of commercial roles across numerous therapeutic categories including oncology, immunology, inflammation, transplantation, chronic obstructive pulmonary disease and asthma.
Mr. Teehan joined Acadia from TESARO where he served as Vice President, building and leading the company’s first provider support function designed to help oncologists optimize patient care.
Mr. Teehan earned a Master of Business Administration from Carnegie Mellon University and a Bachelor of Arts in Government and International Relations from the University of Notre Dame.